Preparation of recombinant rat interleukin-5 by baculovirus expression system and analysis of its biological activities

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1451, Issue 1, 1999, Pages 48-58

  Ishihara, Kenji ^a   Satoh, Ikuko ^a   Nittoh, Takeaki ^a   Kanaya, Toshimichi ^b   Okazaki, Hironobu ^b   Suzuki, Takeo ^b   Koyama, Teruyuki ^b   Sakamoto, Tamami ^c   Ide, Tsuyoshi ^c   Ohuchi, Kazuo ^a  

^a Tohoku University   (Japan)

^b Chuo Sanken Laboratory   (Japan)

^c 861 2202   (Japan)

Author keywords

B Cell growth factor II; Eosinophil differentiation factor; Eosinophil survival enhancing factor; Interleukin 5

Indexed keywords

COMPLEMENTARY DNA; RECOMBINANT INTERLEUKIN 5; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS; CELL DIFFERENTIATION; DRUG ACTIVITY; EOSINOPHIL; GENE EXPRESSION; GENE TRANSFER; HEMOLYMPH; MOLECULAR CLONING; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; RAT; TECHNIQUE; VIRUS RECOMBINANT;

ANIMALS; B-LYMPHOCYTES; BACULOVIRIDAE; BLOTTING, WESTERN; BOMBYX; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE; CELL SURVIVAL; CLONING, MOLECULAR; COLONY-FORMING UNITS ASSAY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EOSINOPHILS; HEMOLYMPH; INTERLEUKIN-5; RATS; RECOMBINANT PROTEINS;

ASCARIS SUUM; BOMBYX MORI; BOMBYX MORI NUCLEOPOLYHEDROVIRUS; CPD VIRUS; CYPOVIRUS; MURINAE; UNIDENTIFIED BACULOVIRUS; UNIDENTIFIED NUCLEAR POLYHEDROSIS VIRUSES;

EID: 0032817309     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4889(99)00090-7     Document Type: Article

References (53)

1. Takatsu K., Tanaka K., Tominaga A., Kumahara Y., Hamaoka T. Antigen-induced T cell-replacing factor (TRF) III. Establishment of T cell hybrid clone continuously producing TRF and functional analysis of released TRF. J. Immunol. 125:1980;2646-2653.
2. Takatsu K., Harada N., Hara Y., Takahama Y., Yamada G., Dobashi K., Hamaoka T. Purification and physicochemical characterization of murine T cell replacing factor (TRF). J. Immunol. 134:1985;382-389.
3. Harada N., Kikuchi Y., Tominaga A., Takaki S., Takatsu K. BCGFII activity on activated B cells of a purified murine T cell-replacing factor (TRF) from a T cell hybridoma (B151K12). J. Immunol. 134:1985;3944-3951.
4. Swain S.L., Dutton R.W. Production of a B cell growth-promoting activity, (DL)BCGF, from a cloned T cell line and its assay on the BCL1 B cell tumor. J. Exp. Med. 156:1982;1821-1834.
5. Sanderson C.J., O'Garra A., Warren D.J., Klaus G.G.B. Eosinophil differentiation factor also has B-cell growth factor activity: proposed name interleukin 4. Proc. Natl. Acad. Sci. USA. 83:1986;437-440.
6. O'Garra A., Warren D.J., Holman M., Popham A.M., Sanderson C.J., Klaus G.G.B. Interleukin 4 (B-cell growth factor II/eosinophil differentiation factor) is a mitogen and differentiation factor for preactivated murine B lymphocytes. Proc. Natl. Acad. Sci. USA. 83:1986;5228-5232.
7. Kinashi T., Harada N., Severinson E., Tanabe T., Sideras P., Konishi M., Azuma C., Tominaga A., Bergstedt-Lindqvist S., Takahashi M., Matsuda F., Yaoita Y., Takatsu K., Honjo T. Cloning of complementary DNA encoding T-cell replacing factor and identify with B-cell growth factor II. Nature. 324:1986;70-73.
8. Yamaguchi Y., Hayashi Y., Sugama Y., Miura Y., Kasahara T., Kitamura S., Torisu M., Mita S., Tominaga A., Takatsu K., Suda T. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med. 167:1988;1737-1742.
9. Wang J.M., Rambaldi A., Biondi A., Chen Z.G., Sanderson C.J., Mantovani A. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur. J. Immunol. 19:1989;701-705.
10. Yamaguchi Y., Suda T., Ohta S., Tominaga K., Miura Y., Kasahara T. Analysis of the survival of mature human eosinophils: interleukin-5 prevents apoptosis in mature human eosinophils. Blood. 78:1991;2542-2547.
11. Fujisawa T., Abu-Ghazaleh R., Kita H., Sanderson C.J., Gleich G.J. Regulatory effect of cytokines on eosinophil degranulation. J. Immunol. 144:1990;642-646.
12. Wardlaw A.J., Dunnette S., Gleich G.J., Collins J.V., Kay A.B. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am. Rev. Respir. Dis. 137:1988;62-69.
13. Azzawi M., Bradley B., Jeffery P.K., Frew A.J., Wardlaw A.J., Knowles G., Assoufi B., Collins J.V., Durham S., Kay A.B. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma. Am. Rev. Respir. Dis. 142:1990;1407-1413.
14. Gibson P.G., Manning P.J., O'Byrne P.M., Girgis-Gabardo A., Dolovich J., Denburg J.A., Hargreave F.E. Allergen-induced asthmatic responses. Relationship between increases in airway responsiveness and increases in circulating eosinophils, basophils, and their progenitors. Am. Rev. Respir. Dis. 143:1991;331-335.
15. Djukanovic R., Wilson J.W., Britten K.M., Wilson S.J., Walls A.F., Roche W.R., Howarth P.H., Holgate S.T. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142:1990;863-871.
16. Durham S.R., Ying S., Varney V.A., Jacobson M.R., Sudderick R.M., Mackay I.S., Kay A.B., Hamid Q.A. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J. Immunol. 148:1992;2390-2394.
17. Naclerio R.M., Baroody F.M., Kagey-Sobotka A., Lichtenstein L.M. Basophils and eosinophils in allergic rhinitis. J. Allergy Clin. Immunol. 94:1994;1303-1309.
18. Barata L.T., Ying S., Meng Q., Barkans J., Rajakulasingam K., Durham S.R., Kay A.B. IL-4- and IL-5-positive T lymphocytes, eosinophils, and mast cells in allergen-induced late-phase cutaneous reactions in atopic subjects. J. Allergy Clin. Immunol. 101:1998;222-230.
19. Leung D.Y.M. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic disease. J. Allergy Clin. Immunol. 96:1995;302-319.
20. Koike M., Takatsu K. IL-5 and its receptor: which role do they play in the immune response? Int. Arch. Allergy Immunol. 104:1994;1-9.
21. Corrigan C.J., Kay A.B. T cells and eosinophils in the pathogenesis of asthma. Immunol. Today. 13:1992;501-507.
22. Bousquet J., Chanez P., Lacoste J.Y., Barnéon G., Ghanavian N., Enander I., Venge P., Ahlstedt S., Simony-Laforntaine J., Godard P., Michel F.-B. Eosinophilic inflammation in asthma. New Engl. J. Med. 323:1990;1033-1039.
23. Hamid Q., Azzawi M., Ying S., Moqbel R., Wardlaw A.J., Corrigan C.J., Bradley B., Durham S.R., Collins J.V., Jeffery P.K., Quint D.J., Kay A.B. Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma. J. Clin. Invest. 87:1991;1541-1546.
24. Humbert M., Corrigan C.J., Kimmitt P., Till S.J., Kay A.B., Durham S.R. Relationship between IL-4 and IL-5 mRNA expression and disease severity in atopic asthma. Am. J. Respir. Crit. Care Med. 156:1997;704-708.
25. Azuma C., Tanabe T., Konishi M., Kinashi T., Noma T., Matsuda F., Yaoita Y., Takatsu K., Hammarström L., Smith C.I.E., Severinson E., Honjo T. Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res. 14:1986;9149-9158.
26. Proudfoot A.E.I., Fattah D., Kawashima E.H., Bernard A., Wingfield P.T. Preparation and characterization of human interleukin-5 expressed in recombinant Escherichia coli. Biochem. J. 270:1990;357-361.
27. Ingley E., Cutler R.L., Fung M.-C., Sanderson C.J., Young I.G. Production and purification of recombinant human interleukin-5 from yeast and baculovirus expression systems. Eur. J. Biochem. 196:1991;623-629.
28. Kunimoto D.Y., Allison K.C., Watson C., Fuerst T., Armstrong G.D., Paul W., Strober W. High-level production of murine interleukin-5 (IL-5) utilizing recombinant baculovirus expression. Purification of the rIL-5 and its use assessing the biologic role of IL-5 glycosylation. Cytokine. 3:1991;224-230.
29. Boodhoo A., Duke N.E.C., Kong D., Ritzel M.W.L., Kunimoto D.Y., Read R.J. Purification, crystallization and preliminary X-ray analysis of murine interleukin-5. J. Mol. Biol. 241:1994;269-272.
30. Überla K., Li W., Qin Z., Richter G., Raabe T., Diamantstein T., Blankenstein T. The rat interleukin-5 gene: characterization and expression by retroviral gene transfer and polymerase chain reaction. Cytokine. 3:1991;72-81.
31. Kitagaki K., Niwa S., Hoshiko K., Nagai H., Hayashi S., Totsuka T. Augmentation of apoptosis in bronchial exuded rat eosinophils by cyclosporin A. Biochem. Biophys. Res. Commun. 222:1996;71-77.
32. Haczku A., Macary P., Haddad E.-B., Huang T.J., Kemeny D.M., Moqbel R., Chung K.F. Expression of Th-2 cytokines interleukin-4 and -5 and of Th-1 cytokine interferon-γ in ovalbumin-exposed sensitized Brown-Norway rats. Immunology. 88:1996;247-251.
33. Cypcar D., Sorkness R., Sedgwick J., Nagata M., Clough J., Kaplan M., Lemanske R.F. Jr. Rat eosinophils: isolation and characterization of superoxide production. J. Leukocyte Biol. 60:1996;101-105.
34. Niki H., Tominaga Y., Watanabe-Kobayashi M., Mue S., Ohuchi K. Possible participation of cyclooxygenase-2 in the recurrence of allergic inflammation in rats. Eur. J. Pharmacol. 320:1997;193-200.
35. Xiao Y.Q., Tanabe J., Edamatsu T., Hirasawa N., Mue S., Ohuchi K. Possible participation of macrophage inflammatory protein 2 in neutrophil infiltration in allergic inflammation in rats. Biochim. Biophys. Acta. 1361:1997;138-146.
36. Watanabe M., Nittoh T., Suzuki T., Kitoh A., Mue S., Ohuchi K. Isolation and partial characterization of eosinophil granule proteins in rats - eosinophil cationic protein and major basic protein. Int. Arch. Allergy Immunol. 108:1995;11-18.
37. Nittoh T., Fujimori H., Kozumi Y., Ishihara K., Mue S., Ohuchi K. Effects of glucocorticoids on apoptosis of infiltrated eosinophils and neutrophils in rats. Eur. J. Pharmacol. 354:1998;73-81.
38. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
39. S. Maeda, Gene transfer vectors of a baculovirus, Bombyx mori nuclear polyhedrosis virus, and their use for expression of foreign genes in insect cells, in: J. Mitsuhashi (Ed.), Invertebrate Cell System Applications, CRC Press, Boca Raton, FL, 1989, pp. 167-181.
40. Suzuki T., Kanaya T., Okazaki H., Ogawa K., Usami A., Watanabe H., Kadono-Okuda K., Yamakawa M., Sato H., Mori H., Takahashi S., Oda K. Efficient protein production using a Bombyx mori nuclear polyhedrosis virus lacking the cysteine protease gene. J. Gen. Virol. 78:1997;3073-3080.
41. Kobayashi J., Imanishi S., Inoue H., Ohsuye K., Yamaichi K., Tsuruoka N., Tanaka S. High level expression of a frog α-amidating enzyme, AE-II, in cultured cells and silkworm larvae using a Bombyx mori nuclear polyhedrosis virus expression vector. Cytotechnology. 8:1992;103-108.
42. Okazaki H., Kanaya T., Nishimura S., Ogawa K., Watanabe H. Peroral inoculation of baculovirus vector to the silkworm, Bombyx mori, treated with a low temperature. J. Seric. Sci. Jpn. 64:1995;504-508.
43. Mita S., Tominaga A., Hitoshi Y., Sakamoto K., Honjo T., Akagi M., Kikuchi Y., Yamaguchi N., Takatsu K. Characterization of high-affinity receptors for interleukin 5 on interleukin 5-dependent cell lines. Proc. Natl. Acad. Sci. USA. 86:1989;2311-2315.
44. Tominaga A., Mita S., Kikuchi Y., Hitoshi Y., Takatsu K., Nishikawa S., Ogawa M. Establishment of IL-5-dependent early B cell lines by long-term bone marrow cultures. Growth Factors. 1:1989;135-146.
45. Kobayashi Y., Saheki T., Shinozawa T. Induction of PC12 cell death, apoptosis, by a sialoglycopeptide from bovine brain. Biochem. Biophys. Res. Commun. 203:1994;1554-1559.
46. Yamaguchi Y., Suda T., Suda J., Eguchi M., Miura Y., Harada N., Tominaga A., Takatsu K. Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors. J. Exp. Med. 167:1988;43-56.
47. S. Maeda, Expression of foreign genes in insect cells using baculovirus vectors, in: K. Maramorosch, A.H. McIntosh (Eds.), Insect Cell Biotechnology, CRC Press, Boca Raton, FL, 1994, pp. 1-13.
48. Ohkawa T., Majima K., Maeda S. A cysteine protease encoded by the baculovirus Bombyx mori nuclear polyhedrosis virus. J. Virol. 68:1994;6619-6625.
49. Clutterbuck E., Shields J.G., Gordon J., Smith S.H., Boyd A., Callard R.E., Campbell H.D., Young I.G., Sanderson C.J. Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B cell growth factor assays. Eur. J. Immunol. 17:1987;1743-1750.
50. Horie S., Gleich G.J., Kita H. Cytokines directly induce degranulation and superoxide production from human eosinophils. J. Allergy Clin. Immunol. 98:1996;371-381.
51. +T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lung. Br. J. Pharmacol. 122:1997;439-446.
52. Nittoh T., Arii M., Suzuki R., Kitoh A., Watanabe M., Mue S., Ohuchi K. Increase in eosinophilic cell population in bone marrow of rats by immunization with Ascaris suum antigen. Immunol. Invest. 26:1997;439-451.
53. Pierrot C., Cocude C., Cêtre C., Godin C., Lafitte S., Capron M., Khalife J. Expression of rat interleukin-5 and generation of neutralizing antiserum: a comparative study of rat IL-5 produced in Escherichia coli and insect cells. Biochem. Biophys. Res. Commun. 253:1998;756-760.